Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Exercise or conversion Pieper Steven acquired 19,483 shares (option exercise)
  2. 4 Open-market buy Director bought 4,515 shares at $2.25 ($10,147)
  3. 4 Open-market buy Director bought 4,285 shares at $2.37 ($10,134)
  4. 4 Shares withheld for taxes Hecht Beth gave up 178,006 shares (to pay taxes)
  5. 4 Shares withheld for taxes JOHNSON KENNETH ERLAND gave up 74,904 shares (to pay taxes)
  6. 4 Shares withheld for taxes Pieper Steven gave up 204,575 shares (to pay taxes)
  7. 4 Shares withheld for taxes Shannon John Patrick Jr gave up 271,551 shares (to pay taxes)
  8. 4 Grant or award McCulloch Kevin acquired 150,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 50,000 shares (grant or award)
  11. 4 Grant or award Director acquired 50,000 shares (grant or award)
  12. 4 Grant or award Director acquired 50,000 shares (grant or award)
  13. 4 Grant or award Director acquired 50,000 shares (grant or award)
  14. 4 Grant or award Director acquired 50,000 shares (grant or award)
  15. 4 Grant or award Director acquired 50,000 shares (grant or award)
  16. 4 Grant or award Director acquired 50,000 shares (grant or award)
  17. 4 Grant or award Director acquired 50,000 shares (grant or award)
  18. 4 Open-market buy Director bought 5,400 shares at $1.91 ($10,314)
  19. 4 Other acquisition Director acquired 6,502 shares (other)
  20. 4 Other acquisition Director acquired 6,474 shares (other)

Page 5 of 9 · 178 filings